Other Capabilities
At ACGTC, we offer a comprehensive range of services designed to advance the field of cell and gene therapy, ensuring that our clients have access to cutting-edge technologies and therapies.
Gene Editing Technologies
Stem Cell Therapies
iPSC (Induced Pluripotent Stem Cell) Development: ACGTC excels in reprogramming adult cells into induced pluripotent stem cells (iPSCs), which can differentiate into various cell types, playing a crucial role in regenerative medicine and personalized therapies.
HSC (Hematopoietic Stem Cell) Therapies: We develop and manufacture therapies involving hematopoietic stem cells, essential for treating blood cancers and immune disorders.
Ocular Stem Cell Therapies: We also focus on stem cell therapies targeting eye diseases, utilizing advanced techniques to restore vision and treat degenerative eye conditions.
Viral Vector Production
AAV (Adeno-Associated Virus) Vectors: Our team is proficient in producing AAV vectors, essential for delivering genes in a variety of gene therapies targeting genetic disorders.
Lentiviral Vectors: We offer expertise in the production of lentiviral vectors, widely used in CAR-T therapies and other cell-based treatments.
Retroviral Vectors: We also specialize in retroviral vector production, particularly for ex vivo gene modification.
Exosome-Based Therapies
Cell Therapy Manufacturing
Autologous and Allogeneic Cell Therapies: We provide comprehensive manufacturing services for both autologous (patient-derived) and allogeneic (donor-derived) cell therapies, ensuring scalable solutions for these critical treatments.
Cell Banking and Expansion: Our facilities offer robust capabilities in cell expansion and cryopreservation, crucial for stem cell and CAR-T/NK therapies.
Regenerative Medicine
Tissue Engineering: ACGTC supports the development of bioengineered tissues, including 3D bioprinting and scaffold development, advancing the field of regenerative medicine.
Wound Healing and Organ Regeneration: We specialize in therapies that promote the regeneration of damaged tissues, including skin, bone, and organ tissue.
Patient-Specific Therapies and Personalized Medicine
Personalized Gene and Cell Therapies: We are at the forefront of developing customized therapies tailored to individual patients, including tumor-infiltrating lymphocytes (TILs) and precision oncology solutions, ensuring that each patient receives the most effective treatment possible.
Gene Delivery Systems
Non-Viral Delivery: In addition to viral vectors, we develop non-viral delivery systems such as electroporation, nanoparticles, and liposomes, essential for specific gene therapies.
Exosome Engineering: ACGTC pioneers in engineering exosomes for the delivery of therapeutic molecules, including RNA, proteins, and drugs, representing an emerging therapeutic modality in cell and gene therapy.
CRISPR-Cas9: We specialize in gene editing using CRISPR, a powerful tool for both ex vivo (modifying cells outside the body) and in vivo (directly in the patient) gene therapies. CRISPR is a cornerstone technology in curing genetic diseases.
At ACGTC, we are dedicated to advancing the field of cell and gene therapy, delivering innovative solutions that improve patient outcomes and support the next generation of therapeutic breakthroughs.
Gene Editing Technologies
Gene Editing Technologies
CRISPR-Cas9: We specialize in gene editing using CRISPR, a powerful tool for both ex vivo (modifying cells outside the body) and in vivo (directly in the patient) gene therapies. CRISPR is a cornerstone technology in curing genetic diseases.
Stem Cell Therapies
Stem Cell Therapies
iPSC (Induced Pluripotent Stem Cell) Development: ACGTC excels in reprogramming adult cells into induced pluripotent stem cells (iPSCs), which can differentiate into various cell types, playing a crucial role in regenerative medicine and personalized therapies.
HSC (Hematopoietic Stem Cell) Therapies: We develop and manufacture therapies involving hematopoietic stem cells, essential for treating blood cancers and immune disorders.
Ocular Stem Cell Therapies: We also focus on stem cell therapies targeting eye diseases, utilizing advanced techniques to restore vision and treat degenerative eye conditions.
Viral Vector Production
Viral Vector Production
AAV (Adeno-Associated Virus) Vectors: Our team is proficient in producing AAV vectors, essential for delivering genes in a variety of gene therapies targeting genetic disorders.
Lentiviral Vectors: We offer expertise in the production of lentiviral vectors, widely used in CAR-T therapies and other cell-based treatments.
Retroviral Vectors: We also specialize in retroviral vector production, particularly for ex vivo gene modification.
Exosome-Based Therapies
Exosome-Based Therapies
Exosome Engineering: ACGTC pioneers in engineering exosomes for the delivery of therapeutic molecules, including RNA, proteins, and drugs, representing an emerging therapeutic modality in cell and gene therapy.
Cell Therapy Manufacturing
Cell Therapy Manufacturing
Autologous and Allogeneic Cell Therapies: We provide comprehensive manufacturing services for both autologous (patient-derived) and allogeneic (donor-derived) cell therapies, ensuring scalable solutions for these critical treatments.
Cell Banking and Expansion: Our facilities offer robust capabilities in cell expansion and cryopreservation, crucial for stem cell and CAR-T/NK therapies.
Gene Delivery Systems
Gene Delivery Systems
Non-Viral Delivery: In addition to viral vectors, we develop non-viral delivery systems such as electroporation, nanoparticles, and liposomes, essential for specific gene therapies.
Regenerative Medicine
Regenerative Medicine
Tissue Engineering: ACGTC supports the development of bioengineered tissues, including 3D bioprinting and scaffold development, advancing the field of regenerative medicine.
Wound Healing and Organ Regeneration: We specialize in therapies that promote the regeneration of damaged tissues, including skin, bone, and organ tissue.
Patient-Specific Therapies and Personalized Medicine
Patient-Specific Therapies and Personalized Medicine
Personalized Gene and Cell Therapies: We are at the forefront of developing customized therapies tailored to individual patients, including tumor-infiltrating lymphocytes (TILs) and precision oncology solutions, ensuring that each patient receives the most effective treatment possible.